Hi Andecker, my concern is capital to continue operations. Sorrento is burning through it like a California wildfire. with 750 million shares in the AS Sorrento is down to somewhere near 260 million shares. At a burn rate of 70 - 80 million shares a quarter that leaves 3 quarters until the barrel is dry. At the end of the first quarter 2023, we will not know results until May and by then another 50 million shares will be sold. At that point Sorento will have to consider its options. There is stock in companies they hold that can be sold but the value of those holdings at that time is unknown.
With the falling market IPO's are in doubt and SPAC's are almost unthinkable especially when investing $140 million in a company that might do $100 million in a year. Sorrento needs a "win" and then production and then revenue. To do that they need production equipment and time. Do they have that time is the question.
An RS is a definite possibility, an FDA approval seems too far out, SEMDEXA if approved could open doors with BP in other studies, the arbitration could extend the clock, Mpro could be the Hail Mary pass that wins the game... lots of balls in the air but time is not our friend.
News 
Market Data 
Discover 
